Hub71 has partnered with European diagnostics company Unilabs to accelerate the development and commercial adoption of health technologies in Abu Dhabi.

Unilabs will join Hub71+ Life Sciences as an anchor market partner, giving HealthTech and life sciences startups access to diagnostic capabilities, clinical expertise, healthcare networks and industry mentorship.

Click here to join our WhatsApp channel here

The partnership is already supporting collaborations with startups including Takalam and GlycanAge. Takalam and Unilabs are developing a personalised mental health and wellbeing offering, while GlycanAge’s biological-age testing technology has been introduced across Unilabs’ healthcare network.

Basma Ahmed AlBadi AlDhaheri, Head of Growth and Value Creation, Hub71, said: “The value of an innovation ecosystem is measured by the outcomes of its connections. By bringing Unilabs together with startups like Takalam and GlycanAge, we are turning startup innovation into economic value for Abu Dhabi. This is how Hub71 contributes to the emirate’s growing Life Sciences sector: by connecting startups to the expertise, infrastructure and market access they need to build and scale from here.”

The collaboration will also support technology integrations, proof-of-concept projects and potential commercial partnerships, helping startups validate and bring innovative healthcare solutions to market.

Also read: Dubai Approves Strategy and Budget for Longevity and Advanced Health

Hub71+ Life Sciences was launched in 2025 to connect startups with regulators, healthcare providers, investors and industry partners across Abu Dhabi’s growing life sciences ecosystem.